HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

PHASE2RecruitingINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

December 8, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

June 30, 2026

Conditions
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute LeukemiaMyelodysplastic SyndromesChronic Myeloid LeukemiaChronic Lymphocytic LeukemiaMyeloproliferative NeoplasmLymphomaChronic Myelomonocytic LeukemiaPro-Lymphocytic LeukemiaMyelofibrosis
Interventions
DRUG

Busulfan

Given IV or PO pre-transplant as part of conditioning regimen

DRUG

Fludarabine

Given IV pre-transplant as part of conditioning regimen

PROCEDURE

PBSC Hematopoietic Stem Cell Transplantation (HSCT)

Peripheral blood stem cell graft is infused from a mismatched unrelated donor on Day 0

DRUG

Post-Transplant Cyclophosphamide

"Cyclophosphamide (25mg/kg) is administered on Day 3 and Day 4 post-transplant as an IV infusion over 1-2 hours.~First 20 subjects with a 4-6/8 HLA mismatched unrelated donor will receive an intermediate dose of post-transplant cyclophosphamide of 37.5 mg/kg Day 3 and Day 4 post-transplant."

DRUG

Mesna

Mesna is given in divided doses IV 30 min pre- and at 3, 6, and 8 hours post cyclophosphamide.

DRUG

Tacrolimus

Tacrolimus is given at a dose of 0.05 mg/kg PO or an IV dose of 0.03 mg/kg of ideal body weight (IBW) starting on Day +5 post-transplant with taper recommended at Day + 90 and finished by Day +180.

DRUG

Mycophenolate Mofetil

Mycophenolate mofetil (MMF) is given at a dose of 15 mg/kg three times daily IV or PO from Day +5 to Day +35 post-transplant.

OTHER

Patient Reported Outcomes

Survey assessments will be administered to study participants pre transplant, at Day + 100, Day + 180, and Day +365 post transplant.

DRUG

Melphalan

Given IV pre transplant as part of conditioning regimen

RADIATION

Total-body irradiation

Administered pre-transplant as part of conditioning regimen

DRUG

Cyclophosphamide

Given IV pre-transplant as part of conditioning regimen

Trial Locations (32)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center - Adults, New York

15232

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

17822

RECRUITING

The Center for Bone Marrow Transplantation at Geisinger, Danville

19104

RECRUITING

Abramson Cancer Center, Philadelphia

21201

RECRUITING

Greenbaum Cancer Center University of Maryland, Baltimore

22908

RECRUITING

University of Virginia Health System, Charlottesville

27599

RECRUITING

University of North Carolina, Chapel Hill

30322

RECRUITING

Emory University, Atlanta

32224

RECRUITING

Mayo Clinic Jacksonville, Jacksonville

33136

RECRUITING

University of Miami Sylvester Cancer Center, Miami

33612

RECRUITING

Moffitt Cancer Center, Tampa

37203

RECRUITING

TriStar Centennial, Nashville

43210

RECRUITING

Ohio State Medical Center, Columbus

48201

RECRUITING

Karmanos Cancer Institute, Detroit

53226

RECRUITING

Froedtert & the Medical College of Wisconsin, Milwaukee

55455

RECRUITING

University of Minnesota, Minneapolis

55902

RECRUITING

Mayo Clinic, Rochester

63110

RECRUITING

Barnes Jewish Hospital / Washington University, St Louis

72205

RECRUITING

University of Arkansas for Medical Sciences, Little Rock

77030

RECRUITING

MD Anderson Cancer Center, Houston

78229

RECRUITING

Methodist Hospital San Antonio, San Antonio

78704

RECRUITING

St. David's South Austin Medical Center, Austin

80218

RECRUITING

Colorado Blood Cancer Institute at Presbyterian St. Luke's, Denver

85054

RECRUITING

Mayo Clinic Arizona, Phoenix

85258

RECRUITING

Honor Health, Scottsdale

91010

RECRUITING

City of Hope, Duarte

94158

RECRUITING

University of California San Francisco, San Francisco

94305

RECRUITING

Stanford University, Stanford

97239

RECRUITING

Oregon Health & Science University, Portland

98109

RECRUITING

Fred Hutchinson Cancer Center, Seattle

02155

RECRUITING

Tufts University, Boston

02215

RECRUITING

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Marrow Donor Program

OTHER

lead

Center for International Blood and Marrow Transplant Research

NETWORK